Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 FORECASTED NEWSFLOW IND filing for Phase 2a study for fibromyalgia Announcement of additional academic collaborations for phantom limb pain and CRPS Enrollment of first patient in Phase 2a study for eating disorders Enrollment of first patient Phase 2a study for phantom limb pain Manufacturing of cGMP Active Pharmaceutical Ingredient (APIԻ Additional intellectual property filings IND filing for CRPS Enrollment of first patient in Phase 2a study for fibromyalgia Disclosure of details on TRPՓ8803 Additional intellectual property filings Enrollment of first patient in Phase 2a study for CRPS Interim data read out for Phase 2a study in eating disorders Completion of preclinical studies for TRPՓ8803 Additional intellectual property filings Interim data read out for Phase 2a study in fibromyalgia Completion of clinical pharmacology study for TRPՓ8803 Additional intellectual property filings 4Q 21 2Q 22 3Q 22 1Q 22 34